Vanderbilt Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232-6838.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Vanderbilt Cancer Center has participated in 54 clinical trials with 3 currently active.
Therapeutic areas: Lung Cancer, Locally Advanced or Metastatic Adenoca of the Biliary Tract, Leukemia.
Sponsors: Eastern Cooperative Oncology Group, OSI Pharmaceuticals, National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt Cancer Center has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt Cancer Center has 54 clinical trials on record, with 3 currently active. Their work covers Lung Cancer, Locally Advanced or Metastatic Adenoca of the Biliary Tract, Leukemia.
Vanderbilt Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.